PM 2.5, O 3 and survival gains from China’s clean air actions among patients with lung cancer: a 20-year registry-based cohort study in Beijing ...
Introduction Preterm-born infants are particularly vulnerable to poor air quality, which may contribute to respiratory ...
Elexacaftor-tezacaftor-ivacaftor (ETI) has transformed cystic fibrosis (CF) care for over 90% of people with CF (pwCF) in countries with access to treatment.1 Clinical trial and ‘real-world’ reports ...
Background Disease modifying therapies for progressive fibrotic interstitial lung diseases (F-ILDs) slow physiological decline but have not consistently shown to improve patient-reported symptoms or ...
‘From exacerbation counts to calibrated risk: lessons from ACCEPT 3.0-UK for COPD prediction models’
Risk assessment in chronic obstructive pulmonary disease (COPD) still depends heavily on a familiar clinical shortcut: a ...
Background Antibiotic therapy before presentation (prior antibiotic exposure, PAE) is reported in 11–39% of patients with ...
Diarrhoea is the primary cause of nintedanib discontinuation in idiopathic pulmonary fibrosis. We investigated predictors in 100 prospective patients; 46% experienced diarrhoea, defined as common ...
Background Inequalities in chronic respiratory diseases persist, yet up-to-date evidence on outcomes remains limited. We described national mortality and exacerbation rates in people with asthma and ...
Background Pulmonary rehabilitation (PR) is the cornerstone of non-pharmacological treatment for chronic obstructive pulmonary disease (COPD), yet fatigue often persists despite rehabilitation. We ...
A 71-year-old man was admitted with presumed pneumonia. He was previously independent, had never smoked and had no history of domestic, environmental or occupational exposures. In the 2 years ...
Background: There is a growing recognition that genetic predisposition contributes to the development of fibrotic interstitial lung disease. Adult onset monogenic disease is most commonly due to ...
Progressive pulmonary fibrosis (PPF) is not merely a diagnostic umbrella; it is a continuous, irreversible cascade of fibroproliferation that carries a mortality rate rivalling many aggressive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results